Risk for Disease, Advanced Stage at Diagnosis Higher With Delayed Colonoscopy After Positive FIT Results

Share this content:
Time between FIT and colonoscopy can vary, with longer intervals potentially allowing cancer progression.
Time between FIT and colonoscopy can vary, with longer intervals potentially allowing cancer progression.

Patients who waited 10 months or longer for follow-up colonoscopy after a positive fecal immunochemical test (FIT) experienced a higher risk of colorectal cancer and an increased rate of advanced-stage disease on diagnosis than did patients who underwent follow-up colonoscopy within 8 to 30 days. As these results are correlative, additional research could assess the nature of this relationship.

FIT, commonly used to screen for colorectal cancer, requires a follow-up colonoscopy for positive test results. The time between FIT and colonoscopy, however, can vary, with longer intervals potentially allowing disease progression.

This retrospective cohort study assessed data from patients in Kaiser Permanente Northern and Southern California between January 2010 and December 2014. Patients (N = 70,124) were aged 50 to 70 years, had a positive result on FIT, and underwent a follow-up colonoscopy.

A total of 2191 diagnoses of colorectal cancer were made, with 601 cases being advanced-stage disease.

No differences in risk of any colorectal cancer or of advanced-stage disease occurred when researchers compared colonoscopy follow-up groups of 8 to 30 days (n = 27,176), 2 months (n = 24,644), 3 months (n = 8666), 4 to 6 months (n = 5251), or 7 to 9 months (n = 1335).

Risks for colorectal cancer and advanced-stage disease were significantly higher for follow-up colonoscopy at 10 to 12 months and longer than 12 months.

These results suggest a need to undergo a follow-up colonoscopy soon after positive FIT results.

Reference

1. Corley DA, Jensen CD, Quinn VP, et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis [published online April 25, 2017]. JAMA. doi: 10.1001/jama.2017.3634

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs